No Prescription |
 |
 | ||
|
PRO BANTHINE Generic Propantheline |
|
| ||
No Prescription » Prescription Drugs 13 » PRO BANTHINE Generic Propantheline Propantheline is used with other medications to treat peptic ulcers. It works by decreasing the release of acid in the stomach.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used with other medications to treat extra stomach acid (e.g. Zollinger-Ellison syndrome) or certain bowel disorders (e.g. irritable bowel syndrome). For bowel disorders the medication works by decreasing the movement of the stomach/intestines.How to use Pro-Banthine OralTake this medication by mouth usually 30 minutes before each meal and at bedtime or as directed by your doctor.Dosage is based on your medical condition and response to therapy.Use this medication regularly to get the most benefit from it. To help you remember take it at the same times each day. Buy PRO BANTHINE Generic Propantheline and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About PRO BANTHINE Generic Propantheline: Product Type: Prescription Drugs 13 PRO BANTHINE ( Generic Propantheline ) PRO BANTHINE (Generic Propantheline) Generic Propantheline 15mg Generic Propantheline PRO BANTHINE
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
